報價延遲最少15分鐘:2026/08/01 08:01 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
5.36 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.18/0.05
|
|
企業價值
77.71M
|
| 資產負債 |
|
每股賬面淨值
0.31
|
| 現金流量 |
|
現金流量率
0.06
|
| 損益表 |
|
收益
59.43M
|
|
每股收益
3.79
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services. |
